Stoke Therapeutics Financial Overview
Stoke Therapeutics's market cap is currently $1.92B. The company's EPS TTM is $-0.65; its P/E ratio is 49.80; Stoke Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
